Fresenius Medical Care AG
FMS· NYSE
Source filing unavailable
| Metric | Q3 2024 | Q3 2023 | Q3 2022 | Q3 2021 |
|---|---|---|---|---|
| Revenue | €4.76B | €4.94B | €5.10B | €4.44B |
| Net Income | €213.03M | €84.35M | €230.10M | €273.04M |
| EPS Diluted | €0.73 | €0.29 | €0.78 | €0.93 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Fresenius Medical Care AG · CIK 1333141 · Engraved from SEC EDGAR